BI 44847
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BI 44847, covering 2014-05-01 to 2014-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes [Phase 1]